Colorectal cancer-derived Foxp3+IL-17+ T cells suppress tumour-specific CD8+ T cells

Scandinavian Journal of Immunology

Volumn 74, Issue 1, 2011, Pages 47-51

  Ma, C ^a   Dong, X ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CELL MARKER; CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER TISSUE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL CANCER; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANTIBODIES; CD8-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; COLONIC NEOPLASMS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; INTERLEUKIN-17; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; TUMOR ESCAPE;

EID: 79958719386     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2011.02539.x     Document Type: Article

References (18)

1. Mocellin S, Nitti D. Therapeutics targeting tumor immune escape: towards the development of new generation anticancer vaccines. Med Res Rev 2008;28:413-44.
2. de la Cruz-Merino L, Henao-Carrasco F, Garca-Manrique T, Ferníndez-Salguero P, Codes-Manuel de Villena M. Role of transforming growth factor-β in cancer microenvironment. Clin Translat Oncol 2009;11:715-20.
3. Knutson KL, Disis ML. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol Immunother 2005;54:721-8.
4. Ramanathan S, Gagnon J, Ilangumaran S. Antigen-nonspecific activation of cytokines; T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer. Arch Immunol Therap Exp 2008;56:311-23.
5. + T-cell population provides the best protection against tumours? Tissue Antigens 2008;72:187-94.
6. + T cell efficacy in vaccination and disease. Nat Med 2008;14:623-8.
7. + regulatory T cells in humans. Proc Natl Acad Sci USA 2009;106:4793-8.
8. Zheng PY, Feng BS, Oluwole C et al. Psychological stress induces eosinophils to produce corticotrophin releasing hormone in the intestine. Gut 2009;58:1473-9.
9. Phillips SM, Banerjea A, Feakins R et al. Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic. Br J Surg 2004;91:469-75.
10. Liu T, He SH, Zheng PY et al. Staphylococcal enterotoxin B increases TIM4 expression in human dendritic cells that drives naive CD4 T cells to differentiate into Th2 cells. Mol Immunol 2007;44:3580-7.
11. Feng BS, Chen X, He SH et al. Disruption of T-cell immunoglobulin and mucin domain molecule (TIM)-1/TIM4 interaction as a therapeutic strategy in a dendritic cell-induced peanut allergy model. J Allergy Clin Immunol 2008;122:55-61.
12. Bierie B, Stover DG, Abel TW et al. Transforming growth factor β regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment. Cancer Res 2008;68:1809-19.
13. Mittendorf EA, Sharma P. Mechanisms of T-cell inhibition: implications for cancer immunotherapy. Expert Rev Vaccines 2009;9:89-105.
14. Zou W, Restifo NP. TH17 cells in tumour immunity and immunotherapy. Nat Rev Immunol 2010;10:248-56.
15. + Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor RORγt. Proc Natl Acad Sci USA 2009;106:8635-40.
16. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T. Regulatory T cells: how do they suppress immune responses? Int Immunol 2009;21:1105-11.
17. Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010;11:7-13.
18. + T cells promote development of cancer-initiating cells in colorectal cancer. J Leukoc Biol 2011;89:85-91.